CD274 and non-small cell lung carcinoma: Based on comparison with the PD-L1 IHC 22C3 pharmDx on the Dako ASL48 platform, both by manual and automated scoring, some conditions were selected for further development in a training set of three NSCLC resection specimens with TPS scores of 70%, 90%, and 100% (determined using the PD-L1 IHC 22C3 pharmDx kit on the Dako ASL48 platform) and are detailed in the Methods section.